Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Apexigen, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
8-K
| Appointed a new director |
| 08/22/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/18/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
8-K
| Other Events Interactive Data |
| 05/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 02/27/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
| 02/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/25/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E... |
| 08/04/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...|
Docs:
|
"Amended and Restated Certificate of Incorporation of the Company",
"Amended and Restated Bylaws of the Company",
"Amended and Restated Warrant Agreement, by and between BCAC and Continental Stock Transfer & Trust Company, LLC",
"Apexigen, Inc. 2022 Equity Incentive Plan and forms of agreements thereunder",
"Apexigen, Inc. 2022 Employee Stock Purchase Plan and forms of agreements thereunder",
"Unaudited pro forma condensed combined financial statements for the Company as of and for the three months ended March 31, 2022 and the year ended December 31, 2021" |
|
| 08/01/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 07/18/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement and Annual Stockholder Meeting to Approve the Proposed Business Combination SAN CARLOS, CA and - July 18, 2022 - On March 18, 2022 Brookline Capital Acquisition Corp. , a life-science focused Special Purpose Acquisition Company affiliated with Brookline Capital Markets, a division of Arcadia Securities, LLC , announced a proposed business combination with Apexigen, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology. The transaction values Apexigen at a $205 million net-equity basis and includes a $15 million fully committed PIPE financing that involves the sale of units consisting of one share of BCAC c..." |
|
| 06/30/2022 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even... |
| 06/27/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Amendment No. 1 to Business Combination Agreement among Brookline Capital Acquisition Corp., Project Barolo Merger Sub, Inc., and Apexigen, Inc., a Delaware corporation",
"Amendment No. 1 to Business Combination Agreement among Brookline Capital Acquisition Corp., Project Barolo Merger Sub, Inc., and Apexigen, Inc., a Delaware corporation" |
|
| 06/02/2022 |
8-K
| Quarterly results |
| 04/26/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Amendment to Amended and Restated Certificate of Incorporation",
"Brookline Capital Acquisition Corp. Announces Stockholder Approval of Extension Amendment to Complete its Business Combination with Apexigen, Inc. - April 26, 2022 - Brookline Capital Acquisition Corp. , a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase reorganization or similar business combination with one or more businesses or entities, today announced that its stockholders approved an extension of the date by which it has to consummate a business combination from May 2, 2022 ) on a monthly basis up to November 2, 2022 . BCAC requested the extension to allow more time to complete its previously announced business combination with A..." |
|
| 03/18/2022 |
8-K
| Quarterly results |
| 03/18/2022 |
8-K
| Quarterly results |
| 12/15/2021 |
8-K
| Quarterly results |
| 06/04/2021 |
8-K
| Quarterly results |
| 02/18/2021 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/08/2021 |
8-K
| Other Events, Financial Statements and Exhibits |
| 02/02/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...|
Docs:
|
"Underwriting Agreement, by and among the Company and Brookline Capital Holdings LLC, as representatives of the several underwriters",
"Amended and Restated Certificate of Incorporation",
"Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent",
"Letter Agreement, by and among the Company, its officers, its directors and the Sponsor",
"Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, between the Registrant and certain security holders",
"Administrative Support Agreement, by and between the Company and Brookline Capital Markets, a division of Arcadia Securities, LLC",
"Unit Subscription Agreement, by and between the Company and the Sponsor",
"Samuel P. Wertheimer Brookline Capital Acquisition Corp.",
"Samuel P. Wertheimer Brookline Capital Acquisition Corp." |
|
|
|